DOSSIER · 13F-HR · Q1 2026

BLACKHILL CAPITAL INC

$1.9B in tracked AUM across 49 positions as of Q1 2026.

BC
CIK 0000872162 · last filed Mar 31, 2026
Total AUM
$1.9B
as of Q1 2026
Holdings
49
positions
Whale Score
75
75
strong
Activity
no data
changes this Q
AI Analysis · Q1 2026

BlackHill Capital's Q1 2026 13F is a $1.94B, 49-position portfolio defined by one extraordinary structural feature: Williams-Sonoma Inc accounts for 72.1% of total AUM ($1.40B on 7.68M shares, up from 70.7% in Q4), making it by far the most concentrated single-issuer exposure in the 13F-HR dataset among funds with meaningful diversification elsewhere. The remaining 28% of AUM is spread across 48 positions in healthcare (Eli Lilly, AbbVie, Abbott, Merck, Bristol Myers, J&J, Zoetis, Zimmer, Pfizer, Elanco), technology (Apple, Microsoft, NVIDIA, Alphabet A+C, F5, Magnite), utilities (Energy Transfer, Essential Utilities, American States Water, American Water Works, Consolidated Edison, Middlesex Water, California Water), consumer defensive (Procter & Gamble, Hershey, Tootsie Roll, Philip Morris), communication services (Disney, Netflix), financial services (Berkshire A+B, Mastercard, Weyerhaeuser, Rayonier, PotlatchDeltic), industrials (Caterpillar, Norfolk Southern), basic materials (Kimberly-Clark), energy (Chevron), and 3 ETFs (SPY, MDY, IWM). The quarter's 50 total changes across 49 positions is relatively high churn driven by a single-file rotation: the manager cut its largest healthcare-and-tech names (Lilly -$22.8M in value despite flat shares, Caterpillar -$0.8M value but -500 shares, Apple -$4.8M value, Bristol Myers -$1.6M value) while increasing Energy Transfer (+$4.0M, +3.4% shares), AbbVie (+$762K, +6.5% shares), and Rayonier (+$311K, +170.8% shares from a 9,093-share base — a new-conviction opening or massive scale-up) and selling one position outright: PotlatchDeltic (-$340K, sold completely). A 77.25 whaleScore on $1.94B reflects the extreme Williams-Sonoma concentration: removing WSM's $1.40B from the AUM calculation leaves a $538M 48-position portfolio that would score significantly lower. The fund's identity is best understood as a Williams-Sonoma-concentrated activist or long-term-quality holder with a diversified tail of mega-cap healthcare, technology, and dividend-paying utility names — the Q1 deltas are minor adjustments within that structure rather than a strategic repositioning. The Williams-Sonoma concentration may reflect a corporate-governance or activist campaign (Williams-Sonoma has been a known activist target) or a long-term-quality-compounding thesis: home-goods retail benefits from housing turnover, renovation spending, and the wealth-effect of US consumer balance sheets. The 49-position structure with 42 unchanged holdings is consistent with a buy-and-hold quality portfolio that rarely trades; the 8 changed positions in Q1 represent the most active quarter in recent history.

BlackHill Capital Inc | CIK 0000872162 | 13F-HR Q1 2026 | 49 positions | $1.94B AUM

The remaining 28% of AUM — approximately $538M spread across 48 positions — is a diversified mega-cap-quality sleeve. Healthcare is the largest non-WSM sector at $289.7M (14.9% of residual AUM) and is composed entirely of large-cap pharmaceutical-and-life-sciences names: Eli Lilly ($134.0M, 6.9%, 145,721 shares, -$22.8M in value but essentially flat shares — pure mark-to-market decline; the manager held), AbbVie ($57.2M, 2.9%, +6.5% shares), Abbott ($27.6M, 1.4%), Merck ($20.3M, 1.0%), Bristol Myers ($16.7M, 0.9%), Johnson & Johnson ($15.7M, 0.8%), Zoetis ($11.3M, 0.6%), Zimmer ($3.8M, 0.2%), and Pfizer ($1.3M, 0.07%). The healthcare sleeve is stable-and-dividend-oriented: every name is a large-cap pharma-with-moat business whose primary appeal is earnings durability and cash-flow generation rather than growth. Eli Lilly is the largest healthcare position and the second-largest position overall; the Q1 value decline of $22.8M is mark-to-market from Lilly's stock-price pullback — the share count held essentially flat (down 243 shares from 145,964 to 145,721), confirming the manager held through the weakness.

Technology is the third-largest sector at $154.5M (8.0% of residual) and consists of Apple ($63.0M, 3.2%, -$4.8M in value but flat shares), Microsoft ($24.4M, 1.3%), NVIDIA ($24.4M, 1.3%), Alphabet Class C ($5.1M, 0.3%), Alphabet Class A ($4.6M, 0.2%), F5 ($463K, 0.02%), and Magnite ($71K, 0.004%). Apple's $4.8M value decline on essentially flat shares is another pure mark-to-market move; the manager held through Apple's Q1 volatility. The NVIDIA-and-Microsoft positions at near-equal weight ($24.4M each) are interesting because both are AI-and-cloud-exposure names that bridge the quality-and-growth narrative; at these weights they are signals-of-conviction rather than passive-index residue. The technology sleeve also includes two tiny legacy positions (F5, Magnite) that have survived multiple quarters at sub-$1M weights.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
WSM
WILLIAMS SONOMA INC COM
$1.4B7.7M72.1%
02
LLY
LILLY ELI & CO COM
$134M146K6.9%
03
AAPL
APPLE INC COM
$63M248K3.2%
04
ABBV
ABBVIE INC COM
$57M263K2.9%
05
CAT
CATERPILLAR INC COM
$42M60K2.2%
06
ABT
ABBOTT LABS COM
$28M269K1.4%
07
MSFT
MICROSOFT CORP COM
$24M66K1.3%
08
NVDA
NVIDIA CORP COM
$24M140K1.3%
09
ET
ENERGY TRANSFER L P COM UNIT L
$23M1.2M1.2%
10
MRK
MERCK & CO INC NEW COM
$20M169K1.0%

Filing history

2026Q1Mar 31
$1.9B 0.0%
49 positionsView →
2025Q4Dec 31
$1.9B 3.8%
50 positionsView →
2025Q3Sep 30
$2.0B 16.5%
51 positionsView →
2025Q2Jun 30
$1.7B 0.8%
49 positionsLocked
2025Q1Mar 31
$1.7B 10.8%
49 positionsLocked
2024Q4Dec 31
$1.9B 11.1%
50 positionsLocked
2024Q3Sep 30
$1.7B 7.7%
52 positionsLocked
2024Q2Jun 30
$1.6B 7.4%
53 positionsLocked
2024Q1Mar 31
$1.7B 39.5%
53 positionsLocked
2023Q4Dec 31
$1.2B 20.3%
52 positionsLocked
2023Q3Sep 30
$1.0B 11.4%
51 positionsLocked
2023Q2Jun 30
$932M 4.0%
51 positionsLocked
Showing 12 of 80